scholarly article | Q13442814 |
P2093 | author name string | Raymond Cheung | |
Margaret Noyes Essex | |||
Pritha Bhadra Brown | |||
Hee-Youn Choi | |||
P2860 | cites work | Nonparametric confidence limits for survival probabilities and median survival time. | Q52730279 |
Gender differences in pressure pain threshold in healthy humans. | Q53658893 | ||
Sex differences in pain: a brief review of clinical and experimental findings | Q26823421 | ||
Gastric mucosal defense and cytoprotection: bench to bedside | Q28283680 | ||
Chronic pain as an outcome of surgery. A review of predictive factors | Q34054244 | ||
Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. | Q34524539 | ||
Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery | Q34525866 | ||
Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery | Q34536863 | ||
Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control | Q34778550 | ||
Ethnic Group Differences in the Outcomes of Multidisciplinary Pain Treatment | Q35073062 | ||
Asians differ from non-Hispanic Whites in experimental pain sensitivity | Q35190446 | ||
Guidelines for the management of postoperative pain after total knee arthroplasty | Q36479149 | ||
Ethnicity, catastrophizing, and qualities of the pain experience | Q36617581 | ||
Trends in use of total knee arthroplasty in Korea from 2001 to 2010. | Q36732359 | ||
Ethnic differences in pain and pain management | Q36846072 | ||
The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery | Q36931151 | ||
Postoperative pain control | Q38179389 | ||
A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty | Q39317038 | ||
Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty | Q39396655 | ||
Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia | Q39398703 | ||
Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis | Q40442987 | ||
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence | Q40485751 | ||
Multimodal pain management after total hip and knee arthroplasty at the Ranawat Orthopaedic Center | Q42060723 | ||
The post-operative analgesic efficacy of celecoxib compared with placebo and parecoxib after total hip or knee arthroplasty. | Q42934324 | ||
Ethnic differences in pain among outpatients with terminal and end-stage chronic illness | Q46081568 | ||
Racial differences in analgesic/anti-inflammatory medication use and perceptions of efficacy | Q46790705 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 427-433 | |
P577 | publication date | 2018-02-23 | |
P1433 | published in | Journal of Pain Research | Q6295704 |
P1476 | title | A randomized study of the efficacy and safety of parecoxib for the treatment of pain following total knee arthroplasty in Korean patients | |
P478 | volume | 11 |
Q91939477 | Comparison of intra-articular injection of parecoxib vs oral administration of celecoxib for the clinical efficacy in the treatment of early knee osteoarthritis |
Q55123465 | Evaluation of the Factors Affecting Concerns and Expectations of Patients Undergoing Total Knee Arthroplasty in China. |
Search more.